Announcement
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene
Nona Biosciences
PR-01-25-NI-02Jan 03, 2025
Strategic Collaboration
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
Amgen
PR-M10-19-NI-048Nov 01, 2019
Clinical Trial
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China
BeiGene
PR-M08-18-NI-115Aug 30, 2018
PD-1 Inhibitor
Celgene Corp. and BeiGene Enter Strategic Collaboration
Guy Tiene
Nice Insight
PAO-M07-17-NI-015Jul 13, 2017